[Plasma estrogen levels in postmenopausal women treated with estrogens alone or combined with medroxyprogesterone acetate in the same tablet].
A study was carried out with 30 postmenopausal women, treated with conjugated estrogens, alone, or associated with medroxyprogesterone acetate in the same tablet, assaying their plasmatic estrogen levels before and during the treatment, besides its clinical efficacy. There were no significative differences of a given doses in neither of both aspects. The conclusion was that the associated hormonal replacement therapy is a good choice that improves patients compliance with the therapy.
Gadán
A
A
Departamento de Obstetricia y Ginecología, Hospital Militar, Santiago, Chile.
D000328:Adult; D000368:Aged; D004338:Drug Combinations; D004341:Drug Evaluation; D004967:Estrogens / Q000097:blood*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D008875:Middle Aged; D017698:Postmenopause / Q000097:blood* / Q000187:drug effects*; D011863:Radioimmunoassay; D013607:Tablets
D004338:Drug Combinations; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D013607:Tablets; D017258:Medroxyprogesterone Acetate
Niveles plasmáticos de estrógenos en mujeres postmenopausicas tratadas con estrógenos solos o asociados a acetato de medroxiprogesterona en un mismo comprimido.